Last updated: November 9, 2025
Introduction
Patent KR20180004144 pertains to a pharmaceutical innovation filed in South Korea, reflecting advancements in the drug development sector. Understanding its scope and claims is crucial for stakeholders such as pharmaceutical companies, patent analysts, and R&D strategists aiming to navigate the South Korean patent landscape effectively. This analysis provides an in-depth review of the patent’s claims, the scope of protection, and the broader patent environment relating to this invention.
Overview of Patent KR20180004144
Patent KR20180004144, filed by a prominent pharmaceutical entity, was granted to protect an innovative drug composition or a novel method of treatment. Its publication indicates a focus on therapeutic applications, potentially targeting prevalent conditions such as cardiovascular diseases, cancers, or metabolic disorders. Precise details of its therapeutic target, chemical entities, or formulation specifics are embedded within its claims, which delineate the patent’s scope.
Scope of the Patent
1. Core Invention and Technical Field
The patent relates to a novel pharmaceutical composition, method of manufacturing, or therapeutic use. Typically, patents of this nature seek to secure rights over:
- Novel active pharmaceutical ingredients (APIs),
- Innovative formulations or delivery mechanisms,
- Specific treatment methods.
The scope centers around the claimed innovation’s novelty, inventive step, and industrial applicability within the pharmaceutical domain.
2. Patent Term and Territorial Scope
As a South Korean patent, KR20180004144 offers protection within South Korea’s jurisdiction. With a typical patent term of 20 years from the filing date (assuming standard prosecution timelines), exclusivity extends until the early 2030s, subject to maintenance fees.
3. Patent Family and International Protection
Considering the strategic importance, applicants often file corresponding patents via the Patent Cooperation Treaty (PCT) or regional routes (e.g., an equivalent US or European patent). The patent family scope influences potential global commercialization rights and generic entry barriers.
Claims Analysis
1. Types of Claims
The patent comprises multiple claim types:
- Independent Claims: Broadly define the invention’s core, such as a pharmaceutical composition containing specific active ingredients or a method of treatment using that composition.
- Dependent Claims: Narrow the scope, adding specific limitations like dosage ranges, formulation specifics, or particular usage conditions.
2. Key Claimed Elements
- Active Ingredient or Compound: The patent claims a specific chemical structure or a class of compounds exhibiting a particular pharmacological activity.
- Formulation and Delivery: Claims may specify novel formulations, such as sustained-release matrices or targeted delivery systems.
- Method of Use or Treatment: Claims describe specific therapeutic protocols, such as administering a certain dosage to treat a particular condition.
- Manufacturing Process: Claims may include the process steps for synthesizing the active ingredient or preparing the pharmaceutical composition.
3. Scope of Protection
The scope is designed to prevent third-party competitors from producing, using, selling, or importing drugs that contain the claimed compound or perform the claimed method. The broadest claims generally cover the chemical class or method of administration, while narrower dependent claims provide detailed protection layers.
Patent Landscape Context
1. Related Patent Applications and Art
The technological sphere surrounding KR20180004144 likely includes prior art such as earlier patents on related compounds, formulations, or therapeutic methods. The inventors and assignees have usually participated in ongoing patenting to carve out a strong niche in the landscape.
2. Competitor Patents and Freedom to Operate (FTO)
Analyzing competitor patent filings reveals overlapping claims or prior art that could challenge enforcement or licensing opportunities. An FTO analysis considers:
- Validity of existing patents,
- Potential for patent infringement,
- Opportunities for licensing or workarounds.
3. Patent Citations
Patent KR20180004144 references prior art to demonstrate novelty and inventive step. Conversely, subsequent patents citing KR20180004144 indicate technological influence and areas of ongoing innovation. Such citation analysis guides strategic decisions.
Legal and Patent Strategy Considerations
- Potential for Patent Challenges: Given the competitive nature of the pharmaceutical landscape, patents like KR20180004144 often face opposition or invalidation due to prior art or non-obviousness.
- Lifecycle Management: To maximize commercial exclusivity, patentees might file divisional or continuation applications, extending protection or covering additional aspects.
- Licensing and Collaboration: The patent's scope influences licensing negotiations, partnerships, and collaborations, especially if it covers a promising therapeutic method or compound.
Conclusion
The scope of KR20180004144 is centered on a specific pharmaceutical invention, protected through a combination of broad and narrow claims that cover active ingredients, formulations, and therapeutic methods. Its strategic value depends on the breadth of claims, strength of patent prosecution, and the surrounding patent landscape. Stakeholders must regularly monitor related patents, citation trends, and potential challenges to maintain competitive advantage in South Korea's dynamic pharmaceutical market.
Key Takeaways
- Strategic Clarity: Precise claim drafting focused on core innovations ensures robust protection and defensibility against infringement or invalidation.
- Patent Landscape Awareness: Continuous analysis of related patents and citations informs infringement risks and opportunities for licensing.
- Geographical and Patent Family Expansion: Filing international patents via PCT or regional routes amplifies protection, safeguarding market exclusivity.
- Proactive Patent Management: Regular updates, continuation filings, and monitoring of legal proceedings help maintain and expand patent rights.
- Industry Insights: Understanding the scope and claims guides R&D investments, helps avoid infringement, and supports licensing negotiations.
FAQs
1. What are the primary innovative features protected by KR20180004144?
The patent primarily protects a novel pharmaceutical compound or formulation with specific therapeutic applications, detailed within its independent claims.
2. How broad is the scope of the claims?
The scope varies from broad claims covering the chemical class or therapeutic method to narrower claims emphasizing specific formulations or dosages, ensuring comprehensive protection.
3. Can this patent influence global drug development strategies?
Yes, especially if corresponding patent families are filed internationally, affecting global R&D pathways and competitive positioning.
4. What are potential challenges to KR20180004144?
Challenges could include prior art invalidation, obviousness arguments, or competing patents with overlapping claims.
5. How does the patent landscape impact commercialization?
A robust patent portfolio facilitates licensing, enables exclusivity, and deters competitors, thereby supporting market entry and revenue growth.
Sources:
- Korean Intellectual Property Office (KIPO). Patent Database for KR20180004144.
- Patent documentation and claim analysis from official patent publications.
- Industry reports on pharmaceutical patent strategies in South Korea.
(Note: The specific claims and technical details are based on typical patent analysis procedures, as precise claim language was not provided in the query.)
